171 related articles for article (PubMed ID: 22804914)
1. Glabellar contraction patterns: a tool to optimize botulinum toxin treatment.
de Almeida AR; da Costa Marques ER; Banegas R; Kadunc BV
Dermatol Surg; 2012 Sep; 38(9):1506-15. PubMed ID: 22804914
[TBL] [Abstract][Full Text] [Related]
2. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
3. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
Alimohammadi M; Andersson M; Punga AR
Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
[TBL] [Abstract][Full Text] [Related]
4. A study on glabellar wrinkle patterns in Koreans.
Kim HS; Kim C; Cho H; Hwang JY; Kim YS
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1332-9. PubMed ID: 24168325
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
6. Eyebrow height after botulinum toxin type A to the glabella.
Carruthers A; Carruthers J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
Yamauchi PS; Lowe NJ
Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
[TBL] [Abstract][Full Text] [Related]
8. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
[TBL] [Abstract][Full Text] [Related]
9. Consideration of muscle mass in glabellar line treatment with botulinum toxin type A.
Monheit G; Lin X; Nelson D; Kane M
J Drugs Dermatol; 2012 Sep; 11(9):1041-5. PubMed ID: 23135645
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hyperfunctional facial lines with botulinum toxin].
Böni R; Kargl A; Kreyden OP; Burg G
Praxis (Bern 1994); 2001 Aug; 90(34):1408-12. PubMed ID: 11552321
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
Carruthers A; Carruthers J; Flynn TC; Leong MS
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
[TBL] [Abstract][Full Text] [Related]
12. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
[TBL] [Abstract][Full Text] [Related]
13. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
Prager W; Rappl T
J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
Monheit G; Carruthers A; Brandt F; Rand R
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S51-9. PubMed ID: 17241415
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.
Ascher B; Zakine B; Kestemont P; Baspeyras M; Bougara A; Santini J
J Am Acad Dermatol; 2004 Aug; 51(2):223-33. PubMed ID: 15280841
[TBL] [Abstract][Full Text] [Related]
16. [Can the botulinum toxin prevent aging?].
Le Louarn C
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S92-103. PubMed ID: 19576493
[TBL] [Abstract][Full Text] [Related]
17. Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation.
Kim SB; Kim HM; Ahn H; Choi YJ; Hu KS; Oh W; Kim HJ
Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050994
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
[TBL] [Abstract][Full Text] [Related]
19. An observational study on glabellar wrinkle patterns in Indians.
Kamat A; Quadros T
Indian J Dermatol Venereol Leprol; 2019; 85(2):182-189. PubMed ID: 29620040
[TBL] [Abstract][Full Text] [Related]
20. The cosmetic use of botulinum toxin type B in the upper face.
Sadick NS
Clin Dermatol; 2004; 22(1):29-33. PubMed ID: 15158542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
